Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Toxicology and Applied Pharmacology
|
September 2, 2020
Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
Amy G Aslamkhan, Qiuwei Xu, Amy Loughlin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Hua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
August 9, 2024
Identifying and addressing mentorship gaps in European trauma and emergency surgical training. Results from the Young European Society of Trauma and Emergency Surgery (yESTES) mentorship survey
Stefano Piero Bernardo Cioffi, Laura Benuzzi, Marit Herbolzheimer, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Journal of Medicinal Chemistry
|
January 28, 2015
Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors
J Michael Ellis, Michael D Altman, Alan Bass, et al.
The Journal of Trauma and Acute Care Surgery
|
March 25, 2024
To close or not to close? Wound management in emergent colorectal surgery, an EAST multicenter prospective cohort study
Cristina B Feather, Scott Rehrig, Rebecca Allen, et al.
Journal of Medicinal Chemistry
|
October 27, 2021
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
Thomas J Tucker, Mark W Embrey, Candice Alleyne, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Toxicology and Applied Pharmacology
|
September 2, 2020
Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
Amy G Aslamkhan, Qiuwei Xu, Amy Loughlin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Hua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
August 9, 2024
Identifying and addressing mentorship gaps in European trauma and emergency surgical training. Results from the Young European Society of Trauma and Emergency Surgery (yESTES) mentorship survey
Stefano Piero Bernardo Cioffi, Laura Benuzzi, Marit Herbolzheimer, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Journal of Medicinal Chemistry
|
January 28, 2015
Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors
J Michael Ellis, Michael D Altman, Alan Bass, et al.
The Journal of Trauma and Acute Care Surgery
|
March 25, 2024
To close or not to close? Wound management in emergent colorectal surgery, an EAST multicenter prospective cohort study
Cristina B Feather, Scott Rehrig, Rebecca Allen, et al.
Journal of Medicinal Chemistry
|
October 27, 2021
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
Thomas J Tucker, Mark W Embrey, Candice Alleyne, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Page
of 7